Topical and oral peroxisome proliferator-activated receptor-α agonist ameliorates diabetic corneal neuropathy
- PMID: 38862650
- PMCID: PMC11167005
- DOI: 10.1038/s41598-024-64451-4
Topical and oral peroxisome proliferator-activated receptor-α agonist ameliorates diabetic corneal neuropathy
Abstract
Diabetic corneal neuropathy (DCN) is a common diabetic ocular complication with limited treatment options. In this study, we investigated the effects of topical and oral fenofibrate, a peroxisome proliferator-activated receptor-α agonist, on the amelioration of DCN using diabetic mice (n = 120). Ocular surface assessments, corneal nerve and cell imaging analysis, tear proteomics and its associated biological pathways, immuno-histochemistry and western blot on PPARα expression, were studied before and 12 weeks after treatment. At 12 weeks, PPARα expression markedly restored after topical and oral fenofibrate. Topical fenofibrate significantly improved corneal nerve fibre density (CNFD) and tortuosity coefficient. Likewise, oral fenofibrate significantly improved CNFD. Both topical and oral forms significantly improved corneal sensitivity. Additionally, topical and oral fenofibrate significantly alleviated diabetic keratopathy, with fenofibrate eye drops demonstrating earlier therapeutic effects. Both topical and oral fenofibrate significantly increased corneal β-III tubulin expression. Topical fenofibrate reduced neuroinflammation by significantly increasing the levels of nerve growth factor and substance P. It also significantly increased β-III-tubulin and reduced CDC42 mRNA expression in trigeminal ganglions. Proteomic analysis showed that neurotrophin signalling and anti-inflammation reactions were significantly up-regulated after fenofibrate treatment, whether applied topically or orally. This study concluded that both topical and oral fenofibrate ameliorate DCN, while topical fenofibrate significantly reduces neuroinflammation.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11167005/bin/41598_2024_64451_Fig1_HTML.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11167005/bin/41598_2024_64451_Fig2_HTML.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11167005/bin/41598_2024_64451_Fig3_HTML.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11167005/bin/41598_2024_64451_Fig4_HTML.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11167005/bin/41598_2024_64451_Fig5_HTML.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11167005/bin/41598_2024_64451_Fig6_HTML.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11167005/bin/41598_2024_64451_Fig7_HTML.gif)
![Figure 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11167005/bin/41598_2024_64451_Fig8_HTML.gif)
![Figure 9](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11167005/bin/41598_2024_64451_Fig9_HTML.gif)
Similar articles
-
Oral Peroxisome Proliferator-Activated Receptor-α Agonist Enhances Corneal Nerve Regeneration in Patients With Type 2 Diabetes.Diabetes. 2023 Jul 1;72(7):932-946. doi: 10.2337/db22-0611. Diabetes. 2023. PMID: 36445944 Free PMC article.
-
PPAR-α Agonist Fenofibrate Suppressed the Formation of Ocular Surface Squamous Metaplasia Induced by Topical Benzalkonium Chloride.Invest Ophthalmol Vis Sci. 2020 Mar 9;61(3):54. doi: 10.1167/iovs.61.3.54. Invest Ophthalmol Vis Sci. 2020. PMID: 32232349 Free PMC article.
-
Pathogenic Role of PPARα Downregulation in Corneal Nerve Degeneration and Impaired Corneal Sensitivity in Diabetes.Diabetes. 2020 Jun;69(6):1279-1291. doi: 10.2337/db19-0898. Epub 2020 Mar 25. Diabetes. 2020. PMID: 32213513 Free PMC article.
-
Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.Am J Pathol. 2014 Oct;184(10):2709-20. doi: 10.1016/j.ajpath.2014.06.021. Epub 2014 Aug 7. Am J Pathol. 2014. PMID: 25108226 Free PMC article.
-
Therapeutic effects of fenofibrate on diabetic peripheral neuropathy by improving endothelial and neural survival in db/db mice.PLoS One. 2014 Jan 2;9(1):e83204. doi: 10.1371/journal.pone.0083204. eCollection 2014. PLoS One. 2014. PMID: 24392081 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous